Misplaced Pages

Carbaldrate: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 15:02, 12 May 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit Latest revision as of 23:46, 21 April 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers172,766 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
(11 intermediate revisions by 9 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| verifiedrevid = 387474044 | verifiedrevid = 428764846
| IUPAC_name = | IUPAC_name =
| image = | image =

| CAS_number =
<!--Clinical data-->
| ATC_prefix = A02
| tradename = Basaljel
| ATC_suffix = AB04
| PubChem = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| DrugBank = | pregnancy_US = <!-- A / B / C / D / X -->
| chemical_formula = | pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| molecular_weight =
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| bioavailability =
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| protein_bound =
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| metabolism =
| legal_status =
| elimination_half-life =
| routes_of_administration =
| excretion =

| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
<!--Pharmacokinetic data-->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category= | bioavailability =
| protein_bound =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| metabolism =
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| elimination_half-life =
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| excretion =
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->

| legal_status =
<!--Identifiers-->
| routes_of_administration =
| CAS_number = 41342-54-5
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6931E8LH07
| ATC_prefix = A02
| ATC_suffix = AB04
| PubChem =
| DrugBank =
| ChemSpiderID = 32698025

<!--Chemical data-->
| chemical_formula = (HO)<sub>2</sub>Al(CO<sub>3</sub>)Na·nH<sub>2</sub>O
| molecular_weight =
| smiles = C(=O)().O....
| StdInChI = 1S/CH2O3.Al.Na.3H2O/c2-1(3)4;;;;;/h(H2,2,3,4);;;3*1H2/q;+3;+1;;;/p-4
| StdInChIKey = YJTPLMXDQANDKS-UHFFFAOYSA-J

}} }}
'''Dihydroxialumini sodium carbonate''' is an ].


It is also known as "dihydroxyaluminium sodium carbonate".<ref name="pmid10752672">{{cite journal |author=Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M |title=Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements |journal=Pharmacol. Toxicol. |volume=86 |issue=3 |pages=135–9 |year=2000 |month=March |pmid=10752672 |doi= 10.1034/j.1600-0773.2000.d01-25.x|url=}}</ref> '''Carbaldrate''' ('''dihydroxyaluminum sodium carbonate''') is an ].<ref name="pmid10752672">{{cite journal |vauthors=Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M |title=Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements |journal=Pharmacol. Toxicol. |volume=86 |issue=3 |pages=135–9 |date=March 2000 |pmid=10752672 |doi= 10.1034/j.1600-0773.2000.d01-25.x}}</ref><ref>{{cite web | url = https://www.drugs.com/inactive/dihydroxyaluminum-sodium-carbonate-433.html | title = Dihydroxyaluminum Sodium Carbonate | publisher = ]}}</ref>


==References== ==References==